Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.
about
The role of medications in causing dry eyeClinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertensionGlaucoma: a review of adjunctive therapy and new management strategies.Effects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: a 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucoma.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionA randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprostClinical options for the reduction of elevated intraocular pressureComparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.Emerging drugs for ophthalmic diseases.Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma.The side effects of the prostaglandin analogues.Travoprost in the management of open-angle glaucoma and ocular hypertensionPaired-eye comparison of medical therapies for glaucoma.Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review.Emerging drugs for ocular hypertension.The use of prostaglandin analogs in the uveitic patient.Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure.Pooled results of two randomized clinical trials comparing the efficacy and safety of travoprost 0.004%/timolol 0.5% in fixed combination versus concomitant travoprost 0.004% and timolol 0.5%.Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%.Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.Effect of different dose schedules of travoprost on intraocular pressure and pupil size in the glaucomatous Beagle.Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients.
P2860
Q21296673-46AC35CE-3066-4C98-A15B-723073807812Q26773219-8EF37753-8782-48A7-9A80-36941DC41E6EQ33307040-9D68C8E6-7401-40AA-8F5B-6A99CBF60CAFQ33738963-2FAE4BAA-A0A4-408D-8D86-1A8B3F8C8DD0Q34043309-61D2717C-D31B-4858-9608-DC34137E9534Q34399842-D7646F15-FF32-4140-A5A1-5F1416866149Q34708267-6C3E9C8E-924B-4242-BE72-0839D82EF17FQ35237431-5D999D4E-8462-4A2E-8055-14E311FEE880Q35581180-27A734C2-4267-49EA-9346-6D258FFEA437Q36194178-BCF92794-DE8F-4009-BCED-68E20C9EAAB5Q36689066-61C3341B-E539-46E7-9390-E0C2DC36ACD4Q37236653-BCF92458-5D1D-4A9E-B4B4-20E54E97F401Q37801282-27D00377-F4A5-4F87-B4AE-E59F7D20CF77Q37831356-F45CDFA2-9302-4F62-972F-80E085E42367Q37847182-6F8F751E-B88D-430D-99F7-940ECFE1C9A8Q37940590-6EDDD0B4-9714-41D7-B1F5-9859A7AC152CQ38443489-7471FA58-0644-4792-ACF1-1ACEF7A14A1AQ41883297-39D73FD6-0F80-4BA6-8719-BD12B1557A42Q42132152-42A4521D-8609-4910-B62A-0E513CB83409Q42602131-91E4EC50-7F3E-4579-8CEB-804EF256619BQ44738432-1F878F49-06B7-432D-8272-B227CC712566Q53827949-D42A97EE-9153-4D7D-B9AB-ED6C704BF14A
P2860
Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Comparison of travoprost 0.001 ...... th, masked, multicenter trial.
@en
Comparison of travoprost 0.001 ...... th, masked, multicenter trial.
@nl
type
label
Comparison of travoprost 0.001 ...... th, masked, multicenter trial.
@en
Comparison of travoprost 0.001 ...... th, masked, multicenter trial.
@nl
prefLabel
Comparison of travoprost 0.001 ...... th, masked, multicenter trial.
@en
Comparison of travoprost 0.001 ...... th, masked, multicenter trial.
@nl
P2093
P1433
P1476
Comparison of travoprost 0.001 ...... th, masked, multicenter trial.
@en
P2093
Alan L Weiner
Alberta A Davis
E Kenneth Sullivan
F Darell Turner
Jess T Whitson
Lewis H Silver
Marla Ratliff
Ronald L Fellman
Travoprost Study Group
P304
P356
10.1016/S0161-6420(02)01010-2
P577
2002-05-01T00:00:00Z